Concepedia

Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization

Ashoke Khanwalkar, Aakanksha Rathor, Amelia K. Read, Hassan Paknezhad, Yifei Ma, Peter H. Hwang

International Forum of Allergy & Rhinology · 2022 · 16 citations · 26 references

DOI

Abstract

The addition of a single treatment of submucosal bevacizumab may be associated with additional clinically meaningful benefit for up to 4 months when compared with electrocautery alone.

References

26

The central role of the propensity score in observational studies for causal effects

Paul R. Rosenbaum, Donald B. Rubin · Biometrika · 1983 · 30.1K citations · Full text

, , +21

A 12-Item Short-Form Health Survey

John E. Ware, Mark Kosinski, Susan Keller · Medical Care · 1996 · 16.7K citations

The MOS 36-Item Short-Form Health Survey (SF-36)

Colleen A. McHorney, WARE JOHNE, RACZEK ANASTASIAE · Medical Care · 1993 · 6.6K citations

, , +17

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)

Claire L. Shovlin, Alan E. Guttmacher, Elisabetta Buscarini et al. · American Journal of Medical Genetics · 2000 · 1.7K citations

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Michael S. Gordon, Kim Margolin, Moshe Talpaz et al. · Journal of Clinical Oncology · 2001 · 915 citations